| scholarly article | Q13442814 |
| P50 | author | Miroslaw K Gorny | Q45671710 |
| P2093 | author name string | I A Rooney | |
| S Zolla-Pazner | |||
| M E Peeples | |||
| J P Atkinson | |||
| M Saifuddin | |||
| C J Parker | |||
| M Ghassemi | |||
| G T Spear | |||
| P2860 | cites work | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
| Functional properties of membrane cofactor protein of complement | Q28610962 | ||
| Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
| Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection | Q29547852 | ||
| Viral dynamics in human immunodeficiency virus type 1 infection | Q29547908 | ||
| Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. | Q34061264 | ||
| Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease | Q34274473 | ||
| Physiologic relevance of the membrane attack complex inhibitory protein CD59 in human seminal plasma: CD59 is present on extracellular organelles (prostasomes), binds cell membranes, and inhibits complement-mediated lysis | Q34306071 | ||
| Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria | Q34576112 | ||
| Human immunodeficiency virus (HIV) infection in CD4+ T lymphocytes genetically deficient in LFA-1: LFA-1 is required for HIV-mediated cell fusion but not for viral transmission | Q36229830 | ||
| Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion | Q36230054 | ||
| Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E | Q36339984 | ||
| Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein | Q36351771 | ||
| Phenotypic variation in the response to the human immunodeficiency virus among derivatives of the CEM T and WIL-2 B cell lines | Q36355185 | ||
| Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway | Q36359927 | ||
| Involvement of human leukocyte antigen class I molecules in human immunodeficiency virus infection of CD4-positive cells | Q36635982 | ||
| Complement activation by human monoclonal antibodies to human immunodeficiency virus | Q36638803 | ||
| The control of homologous lysis | Q36705635 | ||
| Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis | Q36795915 | ||
| Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor | Q37686832 | ||
| Decay-accelerating factor: biochemistry, molecular biology, and function | Q38201546 | ||
| The regulators of complement activation (RCA) gene cluster | Q38665434 | ||
| Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures | Q39532102 | ||
| Human serum lyses RNA tumour viruses | Q39953990 | ||
| High level transient expression of a chloramphenicol acetyl transferase gene by DEAE-dextran mediated DNA transfection coupled with a dimethyl sulfoxide or glycerol shock treatment. | Q40461112 | ||
| Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59. | Q41093280 | ||
| Host cell components affect the sensitivity of HIV type 1 to complement-mediated virolysis | Q41459580 | ||
| Presence of a dysfunctional form of CD59 on a CD59+ subclone of the U937 cell line. | Q41478718 | ||
| Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV. | Q41536475 | ||
| Host cell membrane proteins on human immunodeficiency virus type 1 after in vitro infection of H9 cells and blood mononuclear cells. An immuno-electron microscopic study | Q41586309 | ||
| Presence of class II histocompatibility DR proteins on the envelope of human immunodeficiency virus demonstrated by FACS analysis | Q41615394 | ||
| Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation | Q41693641 | ||
| Complement-mediated, antibody-dependent enhancement of HIV-1 infection in vitro is characterized by increased protein and RNA syntheses and infectious virus release | Q43585395 | ||
| Cytomegalovirus in urine specimens has host beta 2 microglobulin bound to the viral envelope: a mechanism of evading the host immune response? | Q43604543 | ||
| Human T-cell leukaemia virus is not lysed by human serum | Q45804305 | ||
| Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum | Q46773389 | ||
| Characterization of rabbit complement component C8. Functional evidence for the species-selective recognition of C8 alpha by homologous restriction factor (CD59). | Q48084817 | ||
| The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum. | Q53851202 | ||
| Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. | Q53861689 | ||
| Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers | Q67672469 | ||
| Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines | Q67972576 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| virion | Q1757347 | ||
| cell line | Q21014462 | ||
| P304 | page(s) | 501-509 | |
| P577 | publication date | 1995-08-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1 | |
| P478 | volume | 182 |
| Q40953980 | A "complement-ary" AIDS vaccine |
| Q34749137 | A high-affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: implications for treatment of HIV-1/AIDS |
| Q39403858 | A novel approach to inhibit HIV-1 infection and enhance lysis of HIV by a targeted activator of complement |
| Q33997980 | A novel trifunctional IgG-like bispecific antibody to inhibit HIV-1 infection and enhance lysis of HIV by targeting activation of complement |
| Q34120941 | A role for caveolin 1 in assembly and budding of the paramyxovirus parainfluenza virus 5. |
| Q39548535 | AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccine |
| Q39609813 | Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64. |
| Q45325397 | Age-Related Macular Degeneration: A Connection between Human Herpes Virus-6A-Induced CD46 Downregulation and Complement Activation? |
| Q56517281 | Analysis of complement-mediated lysis of SIV and SIV-infected cells reveals sex differences in vaccine-induced immune responses in Rhesus macaques |
| Q40518684 | Analysis of the interaction between respiratory syncytial virus and lipid-rafts in Hep2 cells during infection. |
| Q77845857 | Antibody-mediated neutralization of cytomegalovirus: modulation of efficacy induced through the IgG constant region |
| Q37093742 | Application of proteomics technology for analyzing the interactions between host cells and intracellular infectious agents. |
| Q41556124 | Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection |
| Q45739553 | Attachment of human immunodeficiency virus-1 (HIV-1) particles bearing host-encoded B7-2 proteins leads to nuclear factor-kappa B- and nuclear factor of activated T cells-dependent activation of HIV-1 long terminal repeat transcription |
| Q27468625 | Biomedical applications of glycosylphosphatidylinositol-anchored proteins |
| Q41284460 | Bioorthogonal mimetics of palmitoyl-CoA and myristoyl-CoA and their subsequent isolation by click chemistry and characterization by mass spectrometry reveal novel acylated host-proteins modified by HIV-1 infection |
| Q35973601 | Blockage of CD59 Function Restores Activities of Neutralizing and Nonneutralizing Antibodies in Triggering Antibody-Dependent Complement-Mediated Lysis of HIV-1 Virions and Provirus-Activated Latently Infected Cells |
| Q36158037 | CD59 incorporation protects hepatitis C virus against complement-mediated destruction. |
| Q33794467 | Cellular compartments of human immunodeficiency virus type 1 replication in vivo: determination by presence of virion-associated host proteins and impact of opportunistic infection |
| Q33340974 | Cellular proteins in influenza virus particles |
| Q36412305 | Characterization and role of lentivirus-associated host proteins |
| Q34061960 | Comparative analysis of the transforming mechanisms of Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, and Herpesvirus saimiri |
| Q33804431 | Complement Evasion Strategies of Viruses: An Overview |
| Q27469834 | Complement activation is required for induction of a protective antibody response against West Nile virus infection |
| Q34610122 | Complement and HIV-I infection/HIV-associated neurocognitive disorders |
| Q37456637 | Complement and antibodies: a dangerous liaison in HIV infection? |
| Q34162421 | Complement and viral pathogenesis |
| Q28766705 | Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection |
| Q98899849 | Complement opsonization of HIV affects primary infection of human colorectal mucosa and subsequent activation of T cells |
| Q37083678 | Complement opsonization of HIV-1 results in a different intracellular processing pattern and enhanced MHC class I presentation by dendritic cells |
| Q34364911 | Complement opsonization of HIV-1 results in decreased antiviral and inflammatory responses in immature dendritic cells via CR3 |
| Q73992849 | Complement receptors in HIV infection |
| Q45879541 | Complement regulatory proteins are incorporated into lentiviral vectors and protect particles against complement inactivation |
| Q37055637 | Complement-HIV interactions during all steps of viral pathogenesis. |
| Q38673539 | Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir. |
| Q34400002 | Control of the complement system. |
| Q40708603 | Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection |
| Q92675561 | Dengue virus and the complement alternative pathway |
| Q33834852 | Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection |
| Q33842620 | Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation |
| Q45710613 | Direct Binding of Herpes Simplex Virus Type 1 Virions to Complement C3 |
| Q41810495 | Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding. |
| Q33780497 | Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions |
| Q36102200 | Dynamic Association between HIV-1 Gag and Membrane Domains. |
| Q35363127 | Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection |
| Q36506821 | Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent |
| Q39245066 | Effector mechanisms of humoral immunity to porcine reproductive and respiratory syndrome virus |
| Q36366046 | Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). |
| Q40863577 | Expression of MHC class II in T cells is associated with increased HIV-1 expression |
| Q39728306 | Expression of complement regulatory protein on porcine endogenous retrovirus (PERV) depends on molecular size. |
| Q41010789 | Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells |
| Q21245045 | Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection |
| Q36496450 | Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. |
| Q92005460 | Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity |
| Q41741684 | Functions of Antibodies. |
| Q35382894 | Gag induces the coalescence of clustered lipid rafts and tetraspanin-enriched microdomains at HIV-1 assembly sites on the plasma membrane. |
| Q47555792 | Glycosyl-phosphatidylinositol-Anchored Anti-HIV Env Single Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity |
| Q40657302 | Glycosylphosphatidylinositol Anchor Deficiency Attenuates the Production of Infectious HIV-1 and Renders Virions Sensitive to Complement Attack |
| Q30372278 | HIV immunopathogenesis and strategies for intervention. |
| Q37341025 | HIV induced AIDS and related cancers: chronic immune activation and future therapeutic strategies |
| Q92188956 | HSV-2 Cellular Programming Enables Productive HIV Infection in Dendritic Cells |
| Q35882308 | Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions |
| Q35882741 | Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. |
| Q34331007 | Human CD59 incorporation into porcine endogenous retrovirus particles: implications for the use of transgenic pigs for xenotransplantation |
| Q33742139 | Human Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle Sanctuary |
| Q34070440 | Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein |
| Q40368017 | Human herpesvirus 6 open reading frame U14 protein and cellular p53 interact with each other and are contained in the virion |
| Q42794466 | Human immunodeficiency virus type 1 virological synapse formation in T cells requires lipid raft integrity |
| Q29619512 | Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 |
| Q36863847 | Humoral immunity to HIV-1: neutralization and beyond. |
| Q36623129 | Humoral innate immune response and disease. |
| Q38408016 | Immune Protection of Retroviral Vectors Upon Molecular Painting with the Complement Regulatory Protein CD59. |
| Q44953053 | Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors |
| Q41168464 | Incorporation of host complement regulatory proteins into Newcastle disease virus enhances complement evasion. |
| Q35772032 | Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain |
| Q91911120 | Inflammation et virus: déclenchement,contournements et détournements de la réponse inflammatoire au cours des infections virales |
| Q39023294 | Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle |
| Q34000215 | Integrity of membrane lipid rafts is necessary for the ordered assembly and release of infectious Newcastle disease virus particles |
| Q39337768 | Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity. |
| Q27489393 | Lipids and membrane microdomains in HIV-1 replication |
| Q57356932 | Membrane transplantation to correct integral membrane protein defects |
| Q40349546 | Metabolic biotinylation of lentiviral pseudotypes for scalable paramagnetic microparticle-dependent manipulation |
| Q33823853 | Minimal incidence of serum antibodies reactive with intact primary isolate virions in human immunodeficiency virus type 1-infected individuals |
| Q36424527 | Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins |
| Q37776790 | Modulation of the host immune response by cowpox virus |
| Q24524170 | Plunder and stowaways: incorporation of cellular proteins by enveloped viruses |
| Q36540060 | Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linked |
| Q39682314 | Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo |
| Q34218827 | Provirus activation plus CD59 blockage triggers antibody-dependent complement-mediated lysis of latently HIV-1-infected cells |
| Q36424011 | Quantitation of HLA proteins incorporated by human immunodeficiency virus type 1 and assessment of neutralizing activity of anti-HLA antibodies |
| Q33589185 | Rationale for a vaccine using cellular-derived epitope presented by HIV isolates |
| Q38341233 | Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope |
| Q34666503 | Relationships between plasma membrane microdomains and HIV-1 assembly |
| Q37850839 | Retroviral matrix and lipids, the intimate interaction |
| Q41413269 | Role of complement and Fc receptors in the pathogenesis of HIV-1 infection |
| Q35134722 | Role of complement in the control of HIV dynamics and pathogenesis |
| Q45424163 | Role of lipid rafts in virus replication |
| Q40049100 | SERPING1 mRNA overexpression in monocytes from HIV+ patients. |
| Q39880641 | Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylation |
| Q51794990 | Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies. |
| Q33782387 | T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1 |
| Q73076599 | Targeting lymph nodes with liposomes bearing anti-HLA-DR Fab' fragments |
| Q40960044 | Tetraspanins displayed in retrovirus-derived virus-like particles and their immunogenicity. |
| Q61812881 | The Incorporation of Host Proteins into the External HIV-1 Envelope |
| Q35976953 | The Trojan exosome hypothesis |
| Q77111813 | The acquisition of host-encoded proteins by nascent HIV-1 |
| Q34212487 | The antiviral activity of antibodies in vitro and in vivo. |
| Q28275986 | The good and evil of complement activation in HIV-1 infection |
| Q40121574 | The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active |
| Q35877952 | The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity |
| Q33817487 | The resistance of retroviral vectors produced from human cells to serum inactivation in vivo and in vitro is primate species dependent. |
| Q37113972 | The role of Fc receptors in HIV prevention and therapy |
| Q34434835 | Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles |
| Q33688595 | Viral complement regulatory proteins |
| Q35122624 | Viral mimicry of the complement system |
| Q27477691 | West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H |
Search more.